| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net income | ||||||||
7,266 | 7,459 | 6,659 | 5,989 | 6,587 | 6,061 | 5,932 | 6,400 | 7,063 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Provision for loan losses | ||||||||
975 | 1,125 | 3,000 | 500 | 625 | 750 | 800 | 900 | 485 |
Depreciation and amortization of premises and equipment | ||||||||
423 | 431 | 291 | 274 | 277 | 269 | 268 | 273 | 306 |
Amortization of intangibles | ||||||||
334 | 373 | 374 | 161 | 161 | 189 | 189 | 189 | 189 |
Net amortization of securities | ||||||||
118 | 102 | 100 | 92 | 94 | 91 | 106 | 99 | 110 |
Amortization of stock-based compensation | ||||||||
215 | 174 | 177 | 182 | 152 | 146 | 144 | 145 | 121 |
Accretion of purchase accounting valuations | ||||||||
-705 | -1,774 | -3,145 | -1,134 | -1,024 | -1,135 | -1,223 | -1,717 | -1,981 |
Net change in deferred loan fees and costs | ||||||||
45 | 19 | 61 | 37 | 99 | -436 | 74 | 38 | 93 |
Change in fair value of mortgage servicing rights ("MSR") and other investments | ||||||||
186 | 954 | 234 | 123 | -536 | 32 | 75 | -296 | 70 |
Loss from sale and disposal of premises and equipment | ||||||||
- | 0 | 0 | 0 | -23 | -766 | 434 | 0 | -123 |
Loss on sale of OREO and valuation allowance | ||||||||
-976 | -36 | 10 | 135 | -36 | 79 | -233 | 38 | -136 |
Proceeds from sales of mortgage loans | ||||||||
31,371 | 40,106 | 24,330 | 14,239 | 7,382 | 12,559 | 7,807 | 9,983 | 7,542 |
Originations of mortgage loans held for sale | ||||||||
33,226 | 38,322 | 26,072 | 13,612 | 7,977 | 11,924 | 7,842 | 9,949 | 7,915 |
Gain on sales of mortgage loans | ||||||||
460 | 627 | 533 | 154 | 87 | 188 | 144 | 128 | 157 |
Realized gain on sale of other investments | ||||||||
- | - | - | - | 234 | - | - | - | - |
Realized (gain) loss on sale of securities available for sale and other investments | ||||||||
- | - | - | - | - | - | - | -47 | 3 |
Undistributed income of UFS joint venture | ||||||||
897 | 842 | 768 | 731 | 594 | 708 | 660 | 586 | 609 |
Undistributed income of Ansay joint venture | ||||||||
891 | 55 | 319 | 543 | 875 | 180 | 176 | 562 | 1,196 |
Net earnings on life insurance | ||||||||
160 | 158 | 157 | 157 | 153 | 303 | 3 | 153 | 149 |
Increase in other assets | ||||||||
869 | -1,365 | 1,306 | 413 | 366 | 377 | 430 | 220 | -1,333 |
Decrease in other liabilities | ||||||||
-6,725 | 2,935 | 4,136 | -1,017 | -4,786 | 5,333 | 1,036 | 129 | -5,278 |
Net cash used in operating activities | ||||||||
-2,114 | 13,508 | 6,930 | 3,604 | -1,394 | 12,886 | 5,591 | 4,478 | 97 |
Cash flows from investing activities, net of effects of business combination: | ||||||||
Activity in securities available for sale and held to maturity: | ||||||||
Sales | ||||||||
- | - | - | - | - | 0 | 1,141 | 3,240 | 86 |
Maturities, prepayments, and calls | ||||||||
23,541 | 3,622 | 3,334 | 4,997 | 1,411 | 5,215 | 3,380 | 3,185 | 3,779 |
Purchases | ||||||||
12,643 | 95,025 | 5,808 | 0 | 3,015 | 3,063 | 3,388 | 6,283 | 10,175 |
Net increase in loans | ||||||||
27,710 | 20,620 | 25,278 | -12,716 | 3,314 | -13,030 | 8,160 | 27,648 | 6,451 |
Dividends received from UFS | ||||||||
435 | 742 | 299 | 783 | 284 | 268 | 736 | 215 | 286 |
Dividends received from Ansay | ||||||||
373 | 371 | 319 | 320 | 319 | 252 | 679 | 250 | 251 |
Proceeds from sale of OREO | ||||||||
1,468 | 612 | 22 | 668 | 402 | 1,921 | 44 | 943 | 828 |
Proceeds from sales of other investments | ||||||||
- | 0 | 0 | 0 | 984 | - | - | - | 2,639 |
Net purchases of Federal Home Loan Bank ("FHLB") stock | ||||||||
640 | - | - | - | - | - | - | - | - |
Net purchases of Federal Reserve Bank ("FRB") stock | ||||||||
1,702 | - | - | - | - | - | - | - | - |
Proceeds from sale of premises and equipment | ||||||||
25 | 0 | 0 | 0 | 0 | 10 | 286 | 0 | 149 |
Purchases of premises and equipment | ||||||||
1,782 | 3,421 | 1,383 | 1,465 | 999 | 1,810 | 509 | 8 | 5,600 |
Net cash used in investing activities | ||||||||
-18,635 | -82,661 | -38,241 | 18,677 | -3,928 | 16,320 | -3,261 | -28,949 | -14,208 |
Cash flows from financing activities, net of effects of business combination: | ||||||||
Net increase in deposits | ||||||||
3,928 | 4,956 | -5,352 | 1,345 | 16,557 | 70,745 | -8,876 | 27,314 | -38,160 |
Net decrease in securities sold under repurchase agreements | ||||||||
-10,079 | 33,664 | -7,833 | -5,450 | -6,005 | 24,191 | -6,135 | -12,446 | -21,689 |
Proceeds from advances of borrowed funds | ||||||||
73,000 | -34,000 | 30,000 | 4,000 | 0 | -1,154,600 | 466,900 | 470,700 | 217,000 |
Repayment of borrowed funds | ||||||||
74,000 | 0 | 0 | 4,000 | 0 | 99,100 | 462,900 | 452,200 | 200,000 |
Repayment of notes payable | ||||||||
- | - | - | - | - | - | - | - | 1,500 |
Dividends paid | ||||||||
1,431 | 1,416 | 1,422 | 1,319 | 1,306 | 1,331 | 1,061 | 1,071 | 1,067 |
Proceeds from sales of treasury stock | ||||||||
- | - | - | - | - | - | - | - | 951 |
Repurchase of common stock | ||||||||
2,968 | 0 | 1,555 | 161 | 2,489 | 2,384 | 246 | 2,171 | 5,648 |
Net cash provided by (used in) financing activities | ||||||||
-11,550 | 37,204 | 23,838 | -5,585 | 6,757 | 43,221 | -12,318 | 32,022 | -50,113 |
Net increase (decrease) in cash and cash equivalents | ||||||||
-32,299 | - | -7,473 | 16,696 | 1,435 | - | - | - | - |
Net increase (decrease) in cash and cash equivalents | ||||||||
- | - | - | - | - | - | - | - | -64,224 |
Supplemental disclosures of cash flow information: | ||||||||
Cash paid during the period for: | ||||||||
Interest | ||||||||
4,809 | 4,761 | 5,060 | 4,906 | 4,211 | 4,243 | 2,744 | 4,567 | 2,886 |
Income taxes | ||||||||
- | - | - | - | - | 2,100 | 1,350 | 2,325 | 0 |
Supplemental schedule of noncash activities: | ||||||||
Loans transferred to OREO | ||||||||
91 | 667 | 3,340 | 194 | 726 | 542 | 119 | 29 | 620 |
MSR resulting from sale of loans | ||||||||
243 | 297 | 234 | 131 | 78 | 117 | 75 | 94 | 70 |
Amortization of unrealized holding gains on securities transferred from available for sale to held to maturity recognized in other comprehensive income, net of tax | ||||||||
-8 | - | -10 | -8 | -9 | - | - | - | - |
Change in unrealized gains and losses on investment securities available for sale, net of tax | ||||||||
1,029 | - | 750 | 1,513 | 1,862 | - | - | - | - |
Amortization of unrealized holding gains on securities transferred from available for sale to held to maturity recognized in other comprehensive income, net of tax | ||||||||
- | - | - | - | - | - | - | - | -32 |
Change in unrealized gain/loss on investment securities available for sale, net of tax | ||||||||
- | - | - | - | - | - | - | - | -1,406 |
Payment of deferred compensation through issuance of treasury stock | ||||||||
3,368 | 0 | 0 | 57 | 57 | 0 | 0 | 0 | 0 |